Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Barbanente

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pharmacological Reports : PR|October 5, 2023
Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cellsJoanna Kopecka, Alessandra Barbanente, Daniele Vitone, et al.
International Journal of Molecular Sciences|April 2, 2020
Platinum(IV) Complexes of <i>trans</i>-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer ResistanceParide Papadia, Katia Micoli, Alessandra Barbanente, et al.
RSC Advances|May 9, 2022
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ringParide Papadia, Valentina Gandin, Alessandra Barbanente, et al.
Journal of Inorganic Biochemistry|April 17, 2025
New oxaliplatin-zoledronate derivatives with potential antitumor activity towards bone tumors and metastasesAlessandra Barbanente, Anna Maria Di Cosola, Mauro Niso, et al.
Molecules (Basel, Switzerland)|July 2, 2021
New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro CytotoxicityAlessandra Barbanente, Rosa Maria Iacobazzi, Amalia Azzariti, et al.
Dalton Transactions (Cambridge, England : 2003)|March 16, 2021
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activityElisabetta Gabano, Beatrice Rangone, Elena Perin, et al.
Journal of Materials Chemistry. B|March 12, 2020
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cellsAlessandra Barbanente, Robin A Nadar, Lorenzo Degli Esposti, et al.
International Journal of Molecular Sciences|July 9, 2022
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral AdministrationAlessandra Barbanente, Valentina Gandin, Cecilia Ceresa, et al.
RSC Advances|February 25, 2026
Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapyAlessandra Barbanente, Anna Maria Di Cosola, Federica Rizzi, et al.
Journal of Inorganic Biochemistry|December 20, 2020
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapyAlessandra Barbanente, Barbara Palazzo, Lorenzo Degli Esposti, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmacological Reports : PR|October 5, 2023
Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cellsJoanna Kopecka, Alessandra Barbanente, Daniele Vitone, et al.
International Journal of Molecular Sciences|April 2, 2020
Platinum(IV) Complexes of <i>trans</i>-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer ResistanceParide Papadia, Katia Micoli, Alessandra Barbanente, et al.
RSC Advances|May 9, 2022
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ringParide Papadia, Valentina Gandin, Alessandra Barbanente, et al.
Journal of Inorganic Biochemistry|April 17, 2025
New oxaliplatin-zoledronate derivatives with potential antitumor activity towards bone tumors and metastasesAlessandra Barbanente, Anna Maria Di Cosola, Mauro Niso, et al.
Molecules (Basel, Switzerland)|July 2, 2021
New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro CytotoxicityAlessandra Barbanente, Rosa Maria Iacobazzi, Amalia Azzariti, et al.
Dalton Transactions (Cambridge, England : 2003)|March 16, 2021
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activityElisabetta Gabano, Beatrice Rangone, Elena Perin, et al.
Journal of Materials Chemistry. B|March 12, 2020
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cellsAlessandra Barbanente, Robin A Nadar, Lorenzo Degli Esposti, et al.
International Journal of Molecular Sciences|July 9, 2022
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral AdministrationAlessandra Barbanente, Valentina Gandin, Cecilia Ceresa, et al.
RSC Advances|February 25, 2026
Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapyAlessandra Barbanente, Anna Maria Di Cosola, Federica Rizzi, et al.
Journal of Inorganic Biochemistry|December 20, 2020
Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapyAlessandra Barbanente, Barbara Palazzo, Lorenzo Degli Esposti, et al.
Pageof 3